Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 21

1.

Knockdown of either filaggrin or loricrin increases the productions of interleukin (IL)-1α, IL-8, IL-18 and granulocyte macrophage colony-stimulating factor in stratified human keratinocytes.

Sakai T, Hatano Y, Zhang W, Fujiwara S, Nishiyori R.

J Dermatol Sci. 2015 Nov;80(2):158-60. doi: 10.1016/j.jdermsci.2015.09.002. Epub 2015 Sep 7. No abstract available.

PMID:
26381575
2.

Novel autosomal dominant mutation in loricrin presenting as prominent ichthyosis.

Pohler E, Cunningham F, Sandilands A, Cole C, Digby S, McMillan JR, Aristodemou S, McGrath JA, Smith FJ, McLean WH, Munro CS, Zamiri M.

Br J Dermatol. 2015 Nov;173(5):1291-4. doi: 10.1111/bjd.13895. Epub 2015 Aug 22. No abstract available.

3.

Barrier Function of the Repaired Skin Is Disrupted Following Arrest of Dicer in Keratinocytes.

Ghatak S, Chan YC, Khanna S, Banerjee J, Weist J, Roy S, Sen CK.

Mol Ther. 2015 Jul;23(7):1201-1210. doi: 10.1038/mt.2015.65. Epub 2015 Apr 21.

4.

Two novel mutations in the LOR gene in three families with loricrin keratoderma.

Hotz A, Bourrat E, Hausser I, Haftek M, da Silva MV, Fischer J.

Br J Dermatol. 2015 Apr;172(4):1158-62. doi: 10.1111/bjd.13414. Epub 2015 Mar 9. No abstract available.

PMID:
25234742
5.

A novel microdeletion in LOR causing autosomal dominant loricrin keratoderma.

Kinsler VA, Drury S, Khan A, Waelchli R, Rukaite G, Barnicoat A, Lench N, Harper JI, O'Shaughnessy RF.

Br J Dermatol. 2015 Jan;172(1):262-4. doi: 10.1111/bjd.13361. Epub 2014 Dec 9. No abstract available.

6.

Progressive symmetrical erythrokeratoderma: report of two Chinese families and evaluation for mutations in the loricrin, connexin 30.3 and connexin 31 genes.

Guo BR, Sun LD, Cui Y, Yang S, Zhang XJ.

Clin Exp Dermatol. 2013 Dec;38(8):925-7. doi: 10.1111/ced.12135. Epub 2013 May 17. No abstract available.

PMID:
23678955
7.

Collodion baby and loricrin keratoderma: a case report and mutation analysis.

Yeh JM, Yang MH, Chao SC.

Clin Exp Dermatol. 2013 Mar;38(2):147-50. doi: 10.1111/j.1365-2230.2012.04426.x. Epub 2012 Jul 25. Review.

PMID:
22831754
8.

mRNA-based skin identification for forensic applications.

Visser M, Zubakov D, Ballantyne KN, Kayser M.

Int J Legal Med. 2011 Mar;125(2):253-63. doi: 10.1007/s00414-010-0545-2. Epub 2011 Jan 11.

9.

Evidence for the absence of mutations at GJB3, GJB4 and LOR in progressive symmetrical erythrokeratodermia.

Wei S, Zhou Y, Zhang TD, Huang ZM, Zhang XB, Zhu HL, Liang BH, Lin L, Deng L.

Clin Exp Dermatol. 2011 Jun;36(4):399-405. doi: 10.1111/j.1365-2230.2010.03974.x. Epub 2010 Dec 24.

PMID:
21198793
10.

Maternal genes and facial clefts in offspring: a comprehensive search for genetic associations in two population-based cleft studies from Scandinavia.

Jugessur A, Shi M, Gjessing HK, Lie RT, Wilcox AJ, Weinberg CR, Christensen K, Boyles AL, Daack-Hirsch S, Nguyen TT, Christiansen L, Lidral AC, Murray JC.

PLoS One. 2010 Jul 9;5(7):e11493. doi: 10.1371/journal.pone.0011493.

11.

Activation of vascular endothelial growth factor receptor 2 in a cellular model of loricrin keratoderma.

Yoneda K, Demitsu T, Nakai K, Moriue T, Ogawa W, Igarashi J, Kosaka H, Kubota Y.

J Biol Chem. 2010 May 21;285(21):16184-94. doi: 10.1074/jbc.M109.056424. Epub 2010 Mar 17.

12.

Protein kinase C delta and eta differently regulate the expression of loricrin and Jun family proteins in human keratinocytes.

Kamioka N, Akahane T, Kohno Y, Kuroki T, Iijima M, Honma I, Ohba M.

Biochem Biophys Res Commun. 2010 Mar 26;394(1):106-11. doi: 10.1016/j.bbrc.2010.02.125. Epub 2010 Feb 23.

PMID:
20184865
13.

Locus 1q21 Gene expression changes in atopic dermatitis skin lesions: deregulation of small proline-rich region 1A.

Jarzab J, Filipowska B, Zebracka J, Kowalska M, Bozek A, Rachowska R, Gubala E, Grzanka A, Hadas E, Jarzab B.

Int Arch Allergy Immunol. 2010;151(1):28-37. doi: 10.1159/000232568. Epub 2009 Aug 6.

14.

Variation in genes of the epidermal differentiation complex in German atopic dermatitis patients.

Stemmler S, Nothnagel M, Parwez Q, Petrasch-Parwez E, Epplen JT, Hoffjan S.

Int J Immunogenet. 2009 Aug;36(4):217-22. doi: 10.1111/j.1744-313X.2009.00858.x.

PMID:
19601998
15.

A novel c.545-546insG mutation in the loricrin gene correlates with a heterogeneous phenotype of loricrin keratoderma.

Song S, Shen C, Song G, Mao X, Yan G, Wang X, Yan M, Zhong N.

Br J Dermatol. 2008 Sep;159(3):714-9. doi: 10.1111/j.1365-2133.2008.08657.x. Epub 2008 Aug 21.

PMID:
18844868
16.

Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6.

Kim BE, Leung DY, Boguniewicz M, Howell MD.

Clin Immunol. 2008 Mar;126(3):332-7. doi: 10.1016/j.clim.2007.11.006. Epub 2007 Dec 31.

17.

De novo occurrence of the 730insG recurrent mutation in an Italian family with the ichthyotic variant of Vohwinkel syndrome, loricrin keratoderma.

Drera B, Tadini G, Balbo F, Marchese L, Barlati S, Colombi M.

Clin Genet. 2008 Jan;73(1):85-8. Epub 2007 Oct 22. No abstract available.

PMID:
17953701
18.

Characterization of the loricrin (LOR) gene as a positional candidate for the PSORS4 psoriasis susceptibility locus.

Giardina E, Capon F, De Rosa MC, Mango R, Zambruno G, Orecchia A, Chimenti S, Giardina B, Novelli G.

Ann Hum Genet. 2004 Nov;68(Pt 6):639-45.

19.

Structural and functional consequences of loricrin mutations in human loricrin keratoderma (Vohwinkel syndrome with ichthyosis).

Schmuth M, Fluhr JW, Crumrine DC, Uchida Y, Hachem JP, Behne M, Moskowitz DG, Christiano AM, Feingold KR, Elias PM.

J Invest Dermatol. 2004 Apr;122(4):909-22.

20.

Supplemental Content

Support Center